Disclosure Of Interests In Other Entities [Text Block]

Isofol Medical - Filing #701189

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	394 609 SEK	—	—	—	139 841 SEK	—	—
Non-current assets	6 755 SEK	—	—	—	8 289 SEK	—	—
Current liabilities	83 020 SEK	—	—	—	8 0 124 SEK	—	—
Non-current liabilities	110,000 SEK	—	—	—	1 439 SEK	—	—
Revenue	—	22 407 SEK	—	—	—	37 119 SEK	—
Profit (loss)	—	20 0 251 SEK	200 251 SEK	188 992 SEK	—	188 992 SEK	—
Comprehensive income	—	200 251 SEK	20 0 251 SEK	188 992 SEK	—	188 992 SEK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	379 448 SEK	—	—	—	116 393 SEK	—	126 983 SEK
Depreciation and amortisation expense	—	1 596 SEK	—	—	—	1 770 SEK	—
Tax expense (income)	—	– SEK	—	—	—	1,000 SEK	—